Mednax Q3 top-line up 5%; non-GAAP EPS up 6%

Mednax (MD) Q3 results: Revenues: $888.7M (+4.7%).

Net loss: ($1,260.2M); loss/share: ($15.29); non-GAAP Net Income: $75.5M (-4.3%); non-GAAP EPS: $0.91 (+5.8%); CF Ops: $155.9M (+15.3%).

Q4 Guidance: non-GAAP EPS: $0.87 – 0.95; Revenue growth: 1% – 3%; non-GAAP EBITDA: $125M – 135M.

Previously: Mednax EPS in-line, beats on revenue (Nov. 1)

https://seekingalpha.com/news/3512936-mednax-q3-top-line-5-percent-non-gaap-eps-6-percent